Pfizer spends more money on public relations (read ‘paid articles’ and ‘political lobbying’) than it does on research and development, which is one reason why, when you read mainstream media or listen to politicians, you might think that mRNA vaccination has been a great success and should be expanded.
Well, it has been a financial success; Pfizer earns close to $1,000 every second from mRNA vaccine sales—a total of $36 billion in 2021 and currently growing fast.
